We report here the molecular study of a t(11;19)(q13;p13) translocation observed in a case of Bcell chronic lymphocytic leukemia. This translocation leads to the juxtaposition of the CCND1 gene on chromosome 11 to a new transcriptionnal unit on chromosome 19. The cDNA of this new evolutionarily conserved gene (named FLRG for Follistatin-Related Gene) codes for a secreted glycoprotein of the follistatinmodule-protein family. FLRG is expressed in a wide range of human and murine adult tissues and its expression seems to be tightly regulated during murine embryogenesis. Its transcripts could not be detected in hematopoietic cells from all lineages and in particular in cells from lymphoid B and T lineage except in the t(11;19)-carrying leukemia described here. A great variability of expression is observed among the other tumoral cell lines analysed. Besides the t(11;19)-carrying leukemia described in this work, structural rearrangements of the FLRG locus have been found in a nonHodgkin lymphoma, suggesting that it may play a role in leukemogenesis.
Keywords: FLRG; follistatin; chromosomal translocation; carcinogenesis A majority of human hematopoietic malignancies carry nonrandom chromosomal alterations; experimental evidence indicates that genes located at recurring chromosomal breakpoints are directly involved in tumor pathogenesis (Rabbitts, 1994) . In a previous work, we have reported the molecular study of a t(11;19)(q13;p13) chromosomal translocation observed in a B-cell chronic lymphocytic leukemia (Rimokh et al., 1993) . Cytogenetic analysis of the fresh leukemic cells and of the corresponding cell line revealed, in all the metaphases analysed, the following karyotype: 46, XX, t(l;X)(p21;q27), t(8;9)(q24;p21), t(11;19)(q13;p13). The cell line established from these cells (GOB cell line) shows the same immunophenotype and the same karyotypic anomalies as the parental cells. This translocation involved CCND1 locus on chromosome 11q13 and resulted in the production of an aberrant CCND1 transcript where the 3' UTR of CCND1 was fused to a member of the MER11 sequence family (Medium reiteration frequency repetitive sequences) (Rimokh et al., 1994) . In the present study we report the molecular cloning of the t(11;19) chromosomal breakpoints and show that the CCND1 gene is juxtaposed to a chromosome 19 coding region (named FLRG for Follistatin-Related Gene) whose protein product is homologous to members of a protein family known as the follistatin-module-protein family. These proteins act as growth/dierentiation factors through paracrine control during embryogenesis and adult life (Besecke et al., 1996; Graham and Lunsden, 1996) .
Previous analysis (Rimokh et al., 1994) of the aberrant CCND1 mRNA expressed in this t(11;19)-carrying leukemia had allowed us to locate the breakpoint on the der(11) chromosome at nucleotide 2276 of the cDNA CCND1 sequence (Motokura et al., 1991) , in the 3' untranslated region. To analyse this rearrangement, a genomic phage library prepared from GOB cells was screened with the 35PS and 14EX probes which surround the chromosomal breakpoints on the der(11) chromosome (Figure 1a) . In this way, we were able after restriction mapping analysis to isolate recombinant bacteriophages containing inserts representative of the normal chromosome 11, of the der(11) and der(19) chromosomes. The O2BS probe originating from the der(19) chromosome was then used to screen a placental genomic DNA library and allowed us to clone recombinant phages corresponding to the normal chromosome 19 counterpart ( Figure 1a) . Southern blot analysis of interspecies somatic hybrids DNA and FISH analysis con®rmed the location of FLRG on chromosome 19 at band 19p13 (data not shown). Finally, the O2BS probe derived from the der(19) chromosome and the chromosome 11 14EX probe detected the same rearranged band in BglII and BamHI-cleaved GOB DNA as expected in this t(11;19)-carrying leukemia (Figure 1b) .
We next determined the nucleotide sequence spanning the breakpoints on both parental and translocated chromosomes. On chromosome 11, the break occurred at nucleotide 2276 in the 3' untranslated region of the last CCND1 exon. Two extranucleotides (AA) are present at the chromosomal junction on the der(11) chromosome and ®ve (GAAAG) at the chromosomal junction on the der(19) chromosome. Furthermore, deletion of short stretches of nucleotides occurred on both parental chromosomes during the translocation process ( Figure  1c) . No recombination signal sequences were observed in the vicinity of the breakpoints.
In order to identify a transcriptional unit on 19p13, unique fragments that spanned 19pl3 sequences were used as probes against Northern blots containing RNA from GOB cells and from dierent normal and tumoral human tissues and from cell lines of various origin. The 1SB probe (Figure 1a) hybridized to a transcript of approximately 2.5 kb present in total RNA extracted from the leukemic GOB cells and from normal human tissues. Then, this probe was used to screen a human placenta cDNA library (lDR2 phage, Clontech Laboratories, CA, USA). Seven positive clones were isolated, their restriction mapping and their partial sequence showed that they all coded for the same protein. The sequence of the longest clone (Genbank accession no. U76702) exhibits an open reading frame coding for a peptide of 263 amino acids, predicted molecular weight 27.6 kDa, and a 1700 nt long 3' untranslated region. The longest open reading frame contains two possible ATG initiation codons (nucleotide 8 and 86); the second has the better initiation sequence consensus: CCATGG (Kozac, 1986) . A consensus polyadenylation site AATAAA is found 1666 bases 3' of the stop codon. Comparison of the human cDNA and genomic DNA sequences revealed that the FLRG gene extends over 7 kbp and contains ®ve exons ( Figure 1a ) with typical splice donor and acceptor sites at the intron-exon junctions (data not shown). It must be pointed out that the chromosomal breakpoint of the t(11;19) observed in GOB cells occurred about 7 kbp upstream of FLRG and thus, that all the coding region is maintained on the derivative chromosome 19.
Northern blot analysis con®rmed that FRLG is mainly transcribed as a 2.5 kb RNA and showed that it is expressed in a wide spectrum of normal and tumoral tissues (Figure 2 ). In normal human tissues (Figure 2b ), the highest steady-state levels of the 2.5 kb transcripts were observed in placenta, amniocytes, chorionic villosities and bone marrow stromal cells. A weaker expression was observed in ®broblasts, keratinocytes and endothelial cells. It is noteworthy that none of the hematopoietic tissues (tonsil, spleen, lymph node, bone marrow cells) and tumoral cell lines tested expressed the FLRG transcript. Among the tumoral cell lines tested, FLRG was found to be variably expressed as shown in Figure 2a . Northern blot analysis shows that a small 1.3 kb FLRG transcript is detected in some human tissues (Figures 2a and b) . This transcript is likely to correspond to a shorter form of the 2.5 kb RNA as a result of the use of a dierent polyadenylation site since it cannot be detected with a probe speci®c of the 3' untranslated region of the FLRG RNA (data not shown). Zoo-blot analysis under high-stringency conditions using a FLRG cDNA probe showed that sequences homologous to FLRG can be detected in the chicken and mouse genome (data not shown). It must also be pointed out that a 2.2 kb transcript is observed in some murine tissues when using a human FLRG cDNA probe ( Figure 2d ). Northern blot analysis of murine tissues revealed that FLRG transcripts are present in testis, kidney, muscle, lung and heart. During mouse embryogenesis, FLRG is strongly expressed at the 7th days of developement which corresponds to the gastrulation stage; then, its transcription seems to be downregulated ( Figure 2c ). The predicted amino acid sequence of the largest open reading frame was determined from the nucleotide sequence. Sequence analysis of the putative FLRG protein showed the existence of two closely related domains coded by exons 3 and 4 (domain I: amino acids 97 ± 168 and domain II: amino acids 169 ± 244) which are characterized by their richness in cysteine residues. These domains encompass about 55% of the protein. Exon 5 encodes the short 19 amino acids carboxy-terminal part of the molecule and exons 1 ± 2 code for the leader sequence and the N-terminus of the protein.
Comparison of the cDNA sequence with those in the EMBL bank and in the GenBank and analysis of the intron-exon boundaries revealed that the two cysteine-rich repeats present in the FLRG protein are closely related to the class 1-1 follistatin modules (Shimazaki et al., 1988; Patthy and Nikolics, 1993) (the splice junctions occur between the ®rst and second nucleotide of the respective codon) of follistatin, agrin, and SPARC/osteonectin. Apart from these modules, the homology between FLRG and the other members of the follistatin-related protein family (follistatin, agrin, SPARC, SC1, QR1) is not signi®cant. Alignment and comparison of the follistatin modules which characterize this protein family shows that the higher homology is observed between follistatin and FLRG ( Figure 3a) .
Computerized analysis of the amino acid sequence (PROSITE program) showed that the FLRG protein contains two potential N-glycosylation site on Asparagin 73 and 215. The hydropathic pro®le of FLRG obtained by the Kyte and Doolittle program showed a unique region of hydrophobicity at the N-terminus (amino acids 10 ± 30) of the protein. Although there does not exist any potential cleavage site, we hypothesized that this hydrophobic domain corresponds to a signal peptide and that the FLRG protein might be secreted. These predictions are borne out by COS-7 cells expression studies shown in Figure 3b . The FLRG cDNA was subcloned in the expression vector pME18S and transfected into COS-7 by electroporation. Western blot analyses using a polyclonal rabbit anti-GST-FLRG antibody demonstrated the presence of a 33 kDa protein in cell supernatant of transfected COS-7 and in the supernatants of the LOVO, JAR and HELA tumoral cell lines. In GOB cell supernatant the protein is weakly detectable probably as a result of the low transcription rate of FLRG in these cells.
Glycosylation causes the increased size of the 33 kDa protein. Western blot analysis of the trans- FLRG gene in a t(11;19) translocation S Hayette et al fected COS-7 cell supernatant, following Peptide Nglycosidase F digestion, reveals an accumulation of 27 kDa material with concommitant loss of 33 kDa material (Figure 3b ). 27 kDa is in fact the predicted size of the unmodi®ed core protein. This demonstrates the presence of a sizeable amount of N-linked polysaccharide. Like other members of the follistatinrelated protein family, FLRG is a secreted glycoprotein.
Besides this t(11;19)-bearing leukemia, structural rearrangement of FLRG locus was observed in a case of B-cell Non-Hodgkin Lymphoma (NHL). Southern blot analysis of other LNH (eight mantle zone lymphomas, 18 follicular lymphomas and 10 diuse lymphomas) allowed us to show rearrangement of the FLRG locus in one case of B-cell Mantle Zone Lymphoma (Figure 4 ). Cytogenetic analysis was not performed in this tumor. Rerrangement was identi®ed with three restriction endonucleases and restriction mapping analysis showed that the break occurred downstream of the gene, leaving intact its coding region and its 3' untranslated region. Unfortunately, no Cell supernatants of HELA (1), HepG2 (2), LOVO (3), JAR (4), T47D (5), GOB (6), COS-7 transfected by wild type vector PME18S (7), COS-7 transfected by FLRG (8) and COS-7 transfected by FLRG digested by PNGase (9). The polyclonal antisera against FLRG were produced in rabbits by standard methods. A 940 bp BamHI cDNA fragment containing the whole FLRG coding sequence was inserted in frame into the pGEX expression vector generating a GST (Gluthathion-S-Transferase) fusion protein (designated GST ± FLRG). Fusion protein extracts were then prepared and puri®ed by preparative SDS ± PAGE. The region of the gel containing the GST ± FLRG fusion protein was excised, and polyclonal antisera against this protein were produced in rabbits. For Western blot analysis, culture supernatants were separated by SDS-12% polyacrylamide slab gel electrophoresis. For immunodetection, the ®lters were incubated with 1/2000 dilution of the rabbit anti-GST ± FLRG antibody. Fixation of the antibody was revealed by using an ECL detection kit for rabbit antibodies (Amersham Uppsala, Sweden). A pre-immune serum was used as negative control
-6.7 -4.3 Figure 4 Rearrangement of the FLRG locus in a case of B-cell mantle zone lymphoma. Ten micrograms of genomic DNA extracted from a B-cell NHL (B) and normal peripheral blood lymphocyte (T) were digested with XbaI, HindIII and XhoI, electrophoresed through a 0.8% agarose gel, blotted onto a nylon membrane and hybridized to 1SB probe (Figure 1a) . The scale is in kilo-bases mRNA was available and Northern blot could not be carried out. The molecular cloning of this t(11;19) chromosomal translocation led us to identify a new gene on chromosome 19, the FLRG gene, which codes for a protein homologous to members of the follistatinmodule-protein family. Follistatin related proteins constitute a family of extracellular matrix-associated glycoproteins which bind morphogens or growth/ dierentiation factors and regulate their activity during human and animal development. More than ®ve members of this family have been identi®ed so far. Follistatin was the ®rst member of this family to be fully characterized. It is a monomeric protein originally isolated from ovarian¯uid by virtue of its ability to suppress follicle-stimulating hormone from the pituitary (Ueno et al., 1987) . Actually, further studies have revealed that this molecule displays more pleiotropic eects that can be explained by its capability to bind to and inactivate activin, a member of the transforming growth factor b (TGF-b) superfamily (Nakamura et al., 1990; Michel et al., 1993) . Binding of activin by follistatin inhibits activin function on pituitary cells, granulosa cells, embryonal carcinoma cells, osteoblasts, embryogenesis, hepatocytes and erythroid cells (Mathews, 1994) . It has also been demonstrated that follistatin can associate with cell surface proteoglycan, and in this way might modulate activin binding to its receptors (Nakamura et al., 1991) . SPARC/osteonectin is another important follistatinmodule protein. It is a collagen-binding glycoprotein expressed in a variety of tissues during embryogenesis and repair (Lane and Sage, 1994) . It has been shown to induce changes in cell shape, to modulate cell cycle progression and to be associated with cellular events required in tissue remodelling, cell movement and/or proliferation. Agrin, QR1 and SC1 are other follistatinrelated proteins involved in the formation of the vertebrate nervous system (Hoch et al., 1994; Pierani et al., 1995; Mendis et al., 1996) .
As the other members of this gene family, FLRG encodes a secreted glycoprotein and is highly conserved in evolution, a feature that indicates a large selective pressure to conserve speci®c structural and functional characteristics of the protein. Sequences homologous to FLRG can be detected in lower species such as chicken and mouse; partial sequencing of the mouse FLRG (exons 2, 3 and 4) showed an 85% identity at the amino acids level (data not shown). FLRG is expressed in a wide range of human and murine adult and embryonic tissues but its transcripts could not be detected in hematopoietic cells from all lineages and in particular in cells from lymphoid B and T lineage except in the t(11;19)-carrying leukemia described here.
With regards to their wide-ranging eects on cell dierentiation, proliferation and organization, one can assume that deregulated expression of follistatin related genes could participate in cell transformation. The data presented in this paper constitute an argument in favor of this likelihood. In addition to being involved in a t(11;19)-bearing leukemia, the FLRG locus was found to be rearranged in one case of B-cell NHL. The translocation described here leads to an ectopic expression of FLRG, probably as a result of a consecutive alteration of upstream cis-regulating sequences. Interestingly, the B-cell NHL showing rearrangement of the FLRG locus was also chraracterized by rearrangement of the CCND1 locus. Analyses of larger series of tumors with CCND1 rearrangements are indeed necessary to determine if this association is signi®cant or not. In the same way, further studies are needed to determine if the variability of FLRG expression among the tumoral cells analysed, is due to a dierence of expression in the corresponding normal tissue or is a consequence of speci®c genetic alterations involved in the tumoral process.
Rearrangement of the short arm of chromosome 19 is a common event in malignant blood disorders but does not seem to be associated with a particular type of leukemia or lymphoma. Anomalies concerning chromosome 19p mainly consist of translocations involving dierent partner chromosomes. It is noteworthy that a recent work has reported a signi®cant frequency of t(11;19)(q13;p13) in multiple myeloma (Taniwaki et al., 1994) . Neither of the two cases that were made available for us by our Japanese colleagues demonstrated rearrangement of the FLRG locus by Southern blot analysis. This does not rule out the possibility that, in these cases, the chromosomal breakpoints on chromosome 19p might have separated the FLRG coding sequence from distant cisregulating sequences.
The high homology between FLRG and follistatin suggests that these two proteins could be functionally redundant, being able, for example, to bind and to modulate the activity of activin or other members of the TGFb superfamily. It is also to be noted that the distribution pattern of these two proteins is similar during embryogenesis and adult life. This redundancy may explain that, if follistatin is considered as a direct neural inducer in Xenopus (Hemmati-Brivanlou et al., 1994) , its absence during embryogenesis of follistatin nul mice is compatible with the development of a normal peripheral and central nervous system (Matzuk et al., 1995) . In the same way, expression of FLRG by bone marrow stromal cells suggests that FLRG may be implicated in the modulation of hematopoiesis through a paracrine control in the bone marrow microenvironment. In this respect, its biological activity could be compared with that of follistatin which inhibits the erythoid dierentiation activity of activin (also named Erythroid Dierentiation Factor, EDF) in human and mouse (Hino et al., 1995; Yamashita et al., 1992) .
In conclusion, we report here the characterization of a new member of the follistatin-module-protein family that might be involved in the leukemogenesis process. Furthermore, this gene could be of interest in other ®elds of human biology because it belongs to a gene family whose members have been demonstrated to play a major role in the maintenance of tissue homeostasis. Goals for future studies include functional study of this new protein in order to de®ne its role in tumorogenesis and in physiology of normal cells.
